Are increased levels of CRP and MCP-1 associated with previously unknown abnormal glucose regulation in patients with acute STEMI : a cohort study?
Elevated levels of CRP and MCP-1 measured in patients early after an acute STEMI were associated with abnormal glucose regulation classified by an OGTT at three-month follow-up. No significant associations were observed between inflammatory markers and hyperglycaemia measured during the acute STEMI.
It is suggested that SGCCM contains some regulatory substance(s) capable of inhibiting progesterone secretion by cultured granulosa cells and that the molecular weight of such substance is presumably between 10-50 kDa.